BFLY ▲ +5.6% - Butterfly Network, Inc.
$BFLY Needham analyst David Saxon initiated coverage of Butterfly Network with a Buy rating and $10 price target. The company's "differentiated" semiconductor chip base ultrasound system is enabling the development of a new wave of medical technologies that spans many categories, the analyst tells investors in a research note. The firm believes Butterfly can participate in new markets, some of which represent significant opportunities, while its core ultrasound platform represents "multiple sources of near-term upside."
Butterfly Network rose 5.6% after Needham analyst David Saxon initiated coverage with a Buy rating and $10 price target, citing the company's differentiated semiconductor-based ultrasound system and potential to enter new markets while driving near-term growth from its core platform. The positive initiation and price target provided fresh analyst validation for the healthcare technology company's competitive positioning.
22-SEP-2026 09:07 AM ET
Share this post
More filings for $BFLY
BFLY ▼ -1.2% - Butterfly Network, Inc.Oct 8, 2026BFLY ▼ -7.3% - Butterfly Network, Inc.Oct 6, 2026BFLY ▼ -7.1% - Butterfly Network, Inc.Oct 6, 2026BFLY ▲ +0.9% - Butterfly Network, Inc.Oct 5, 2026BFLY ▼ -0.1% - Butterfly Network, Inc.Oct 1, 2026BFLY ▲ +4.2% - Butterfly Network, Inc.Sep 29, 2026
View full $BFLY filing history →💬 Comments
Loading comments…
Leave a comment
